MetaADEDB 2.0 @ LMMD
Ergocalciferols
(MECHNRXZTMCUDQ-RKHKHRCZSA-N)
Structure
SMILES
O[C@H]1CCC(=C)/C(=C\C=C\2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](/C=C/[C@@H](C(C)C)C)C)C)/C1
Type(s)
Approved; Nutraceutical
ATC code(s)
A11CC01
Molecular Formula:
C28H44O
Molecular Weight:
396.648
Log P:
7.6410
Hydrogen Bond Acceptor:
1
Hydrogen Bond Donor:
1
TPSA:
20.23
CAS Number(s):
50-14-6
Synonym(s)
1.
Ergocalciferols
2.
Calciferols
3.
Vitamin D 2
4.
Ergocalciferol
5.
Vitamin D2
6.
D2, Vitamin
External Link(s)
MeSHD004872
PubChem Compound5280793
BindingDB50247883
ChEBI28934
CHEMBLCHEMBL1536
DrugBankDB00153
DrugCentral2838
KEGGcpd:C05441
dr:D00187
ZINC4629876
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1MalnutritionFAERS: 10US FAERS
2Weight decreasedFAERS: 10US FAERS
3AstheniaFAERS: 9US FAERS
4Blood 25-hydroxycholecalciferol increasedFAERS: 9US FAERS
5Blood parathyroid hormone decreasedFAERS: 9US FAERS
6DehydrationFAERS: 9US FAERS
7HypercalciuriaFAERS: 96600835CTD
US FAERS
8HypersensitivityFAERS: 9US FAERS
9NauseaFAERS: 9US FAERS
10PolyuriaFAERS: 9US FAERS
11DysgeusiaFAERS: 8US FAERS
12FatigueFAERS: 8US FAERS
13HeadacheFAERS: 7US FAERS
14NephrocalcinosisFAERS: 79430241
13414150
CTD
US FAERS
15MyalgiaFAERS: 6US FAERS
16VomitingFAERS: 6US FAERS
17Bone painFAERS: 5US FAERS
18MalaiseFAERS: 5US FAERS
19PruritusFAERS: 5US FAERS
20UrticariaFAERS: 5US FAERS
21Abdominal discomfortFAERS: 4US FAERS
22DizzinessFAERS: 4US FAERS
23LethargyFAERS: 4US FAERS
24AbasiaFAERS: 3US FAERS
25Abdominal PainFAERS: 3US FAERS
26AmnesiaFAERS: 3US FAERS
27ArthralgiaFAERS: 3US FAERS
28ConstipationFAERS: 3US FAERS
29Drug dispensing errorFAERS: 3US FAERS
30Incorrect dose administeredFAERS: 3US FAERS
31PainFAERS: 3US FAERS
32SomnolenceFAERS: 3US FAERS
33Toxicity to various agentsFAERS: 3US FAERS
34Unevaluable eventFAERS: 3US FAERS
35Accidental overdoseFAERS: 2US FAERS
36Acute kidney injuryFAERS: 2US FAERS
37AlopeciaFAERS: 2US FAERS
38Blood creatinine increasedFAERS: 2US FAERS
39Chest discomfortFAERS: 2US FAERS
40FlatulenceFAERS: 2US FAERS
41Lip swellingFAERS: 2US FAERS
42Medication residue presentFAERS: 2US FAERS
43Musculoskeletal stiffnessFAERS: 2US FAERS
44NephrolithiasisFAERS: 2US FAERS
45ThirstFAERS: 2US FAERS
46Alanine Aminotransferase IncreasedFAERS: 1US FAERS
47Allergic reaction to excipientFAERS: 1US FAERS
48Anaphylactic shockFAERS: 1US FAERS
49AngioedemaFAERS: 1US FAERS
50Angiotensin converting enzyme increasedFAERS: 1US FAERS
51AnxietyFAERS: 1US FAERS
52Aortic Valve StenosisFAERS: 1US FAERS
53ApathyFAERS: 1US FAERS
54ArthritisFAERS: 1US FAERS
55Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
56AsphyxiaFAERS: 1US FAERS
57AstigmatismFAERS: 1US FAERS
58Atrial FibrillationFAERS: 1US FAERS
59Back PainFAERS: 1US FAERS
60Blood 1,25-dihydroxycholecalciferol increasedFAERS: 1US FAERS
61Blood parathyroid hormone increasedFAERS: 1US FAERS
62Blood urea increasedFAERS: 1US FAERS
63CalciphylaxisFAERS: 1US FAERS
64Cardiac ArrestFAERS: 1US FAERS
65Chest PainFAERS: 1US FAERS
66ChillsFAERS: 1US FAERS
67DeafnessFAERS: 1US FAERS
68Depressed moodFAERS: 1US FAERS
69Drug dose omissionFAERS: 1US FAERS
70Drug level above therapeuticFAERS: 1US FAERS
71Drug toxicityFAERS: 1US FAERS
72Electrolyte imbalanceFAERS: 1US FAERS
73EructationFAERS: 1US FAERS
74Eye irritationFAERS: 1US FAERS
75Eye painFAERS: 1US FAERS
76Failure to ThriveFAERS: 1US FAERS
77Growth retardationFAERS: 1US FAERS
78Head discomfortFAERS: 1US FAERS
79Hypervitaminosis DFAERS: 1US FAERS
80Impaired driving abilityFAERS: 1US FAERS
81Inappropriate schedule of drug administrationFAERS: 1US FAERS
82Intercepted drug administration errorFAERS: 1US FAERS
83Limb discomfortFAERS: 1US FAERS
84Medication ErrorFAERS: 1US FAERS
85Memory impairmentFAERS: 1US FAERS
86Mental impairmentFAERS: 1US FAERS
87Mental status changesFAERS: 1US FAERS
88Morbid thoughtsFAERS: 1US FAERS
89Neck PainFAERS: 1US FAERS
90Nerve injuryFAERS: 1US FAERS
91NocturiaFAERS: 1US FAERS
92OverdoseFAERS: 1US FAERS
93Poor quality sleepFAERS: 1US FAERS
94PurpuraFAERS: 1US FAERS
95Reaction to drug excipientsFAERS: 1US FAERS
96Respiratory arrestFAERS: 1US FAERS
97Respiratory tract irritationFAERS: 1US FAERS
98RhinalgiaFAERS: 1US FAERS
99Skin necrosisFAERS: 1US FAERS
100StressFAERS: 1US FAERS
101TinnitusFAERS: 1US FAERS
102TremorFAERS: 1US FAERS
103Visual ImpairmentFAERS: 1US FAERS
104Vitamin D DeficiencyFAERS: 1US FAERS
105Wheelchair userFAERS: 1US FAERS
106WheezingFAERS: 1US FAERS
107Wrong drug administeredFAERS: 1US FAERS
108muscle injuryFAERS: 1US FAERS
109Arteriosclerosis

View details

CTD
110Atherosclerosis18442015CTD
111Azotemia9430241CTD
112CalcinosisCanada Vigilance: 1Canada Vigilance
113Familial Hypophosphatemic Rickets9430241CTD
114Gastrointestinal Hemorrhage18049428
18442015
CTD
115Hepatitis C17420205CTD
116Hypercalcemia

View details

CTD
117Hypoparathyroidism8528347CTD
118Juvenile osteoporosis5305802CTD
119Osteomalacia4148461CTD
120Ulcer18049428
18442015
CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.